在纳米分子度下,大麻素会对通过腺素A2A受体的信号传输产生负面影响
Iu Raïch1,2, Jaume Lillo2,3, Carlos Ferreiro-Vera4
1Department of Biochemistry and Physiology, School of Pharmacy and Food Science, Universitat de Barcelona, 08028 Barcelona, Spain.
International journal of molecular sciences
|December 23, 2023
概括
大麻素 (CBD) 可能调节腺A2A受体. 研究表明,CBD充当负基调制剂,影响受体信号通路,但不直接结合主部位.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 大麻素 (CBD) 是一种具有治疗潜力的植物性大麻素.
- CBD可能与G蛋白合受体 (GPCRs) 相互作用,包括腺A2A受体.
- 了解CBD与A2A受体的相互作用对于其治疗应用至关重要.
研究的目的:
- 为了研究大麻素 (CBD) 对人类腺A2A受体的功能的影响.
- 为了确定CBD是否与orthosteric部位结合或调节信号传输.
- 阐明CBD对A2A受体信号传递的作用机制.
主要方法:
- 均的结合和信号测试是在中国仓鼠卵巢 (CHO) 细胞中进行的.
- 细胞表达了人类的腺A2A受体.
- 试验评估了CBD竞争对手结合和调节对手诱导信号的能力.
主要成果:
- CBD没有竞争在选择性A2A受体对手的结合在orthosteric网站.
- CBD降低了A2A受体的激素诱导的Gs合.
- CBD抑制了由A2A受体激动剂激活基因酶信号通路的激活.
结论:
- Cannabidiol (CBD) 不结合到腺A2A受体的正经位点.
- CBD作为A2A受体的负基调制剂.
- 对于CBD对A2A受体信号通路的调节,需要进一步研究治疗开发.
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
825
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
825
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
882
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
882
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
199
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
199


